SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

14 May 2024 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 May 2024 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

07 May 2024 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

24 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

13 Mar 2024 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

06 Mar 2024 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

28 Feb 2024 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

08 Nov 2023 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

01 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

19 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

05 Sep 2023 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

10 Aug 2023 15:01:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

03 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

01 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 Jul 2023 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

23 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

31 May 2023 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

10 May 2023 15:01:00 By Nasdaq GlobeNewswire